An immunoglobulin complex preparation, or simply “CIP”, is determined by the instructions for use as an immunostimulating drug designed to enhance specific immunity. This tool significantly increases the content of antibodies to enteroviruses and enterobacteria such as Salmonella, Shigella and Escherichia. In addition, the medicine "KIP", the price of which is about seven hundred rubles, effectively increases the amount of immunoglobulins contained in the blood. At the same time, the manufacturing company emphasizes that this drug does not contain antibiotics or preservatives. The immunobiological characteristics of this drug are directly related to the presence of IgA, IgG and IgM.
The composition of the drug and the form of release
The drug
"KIP" is produced
(instructions for use are in each package) in the form of a lyophilisate, intended for the preparation of a solution for further oral administration. The concentrate itself is an amorphous mass of blue or white. The composition of this
immunostimulating agent as the main element includes three hundred milligrams of
human immunoglobulin. The role of an auxiliary ingredient is glycine. The latter is contained in a volume of one hundred milligrams.
List of indications for use
The instructions for use advise people who suffer from acute forms of intestinal infections and dysbacteriosis, which developed after undergoing chemotherapy or as a result of the negative effects of radiation, to prescribe the "KIP" remedy. In addition, this drug is quite actively used during immunocorrective therapy in young patients. So, it recommends taking the "KIP" tool for use in children with poor health, premature babies, as well as those babies who are breast-fed. In addition, this drug is indicated for use in order to prevent the development of infectious diseases in people with so-called acquired immunodeficiency and in people who have a lowered immune status (elderly, disabled).
Contraindications and Precautions
To prescribe the
"KIP" remedy
, the instructions for use categorically forbid patients suffering from individual glycine intolerance. People with an allergic reaction to immunoglobulin should also refuse to use this immunostimulating drug. True, in some cases, treatment can be continued using
antihistamines. In addition, the drug should not be used in the absence of mandatory labeling of the vial containing the lyophilisate, in case of violation of its integrity, in case of a change in physical properties or the presence of any foreign matter. If the storage temperature established by the manufacturer is not observed, this immunostimulating agent should also not be used.